Home/Filings/4/0001604643-23-000080
4//SEC Filing

Stas Benedict J. 4

Accession 0001604643-23-000080

CIK 0001604643other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:25 PM ET

Size

20.0 KB

Accession

0001604643-23-000080

Insider Transaction Report

Form 4
Period: 2023-05-24
Stas Benedict J.
EVP, CFO & Treasurer
Transactions
  • Award

    Common Stock

    2023-05-24+42,413285,326 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-248,4640 total
    Exercise: $7.42Exp: 2026-10-28Common Stock (8,464 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2455,6920 total
    Exercise: $24.76Exp: 2031-02-16Common Stock (55,692 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2474,3190 total
    Exercise: $23.63Exp: 2030-02-14Common Stock (74,319 underlying)
  • Disposition to Issuer

    Common Stock

    2023-05-24285,3260 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-24200,0000 total
    Exercise: $4.64Exp: 2025-04-06Common Stock (200,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2478,7390 total
    Exercise: $20.88Exp: 2028-04-02Common Stock (78,739 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2490,9090 total
    Exercise: $12.67Exp: 2029-02-14Common Stock (90,909 underlying)
Footnotes (7)
  • [F1]Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023.
  • [F2]Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
  • [F3]This option is fully vested.
  • [F4]Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
  • [F5]Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.
  • [F6]This option vests in four equal annual installments starting on Jan. 1, 2021.
  • [F7]This option vests in four equal annual installments starting on Feb. 16, 2022.

Issuer

Evoqua Water Technologies Corp.

CIK 0001604643

Entity typeother

Related Parties

1
  • filerCIK 0001720175

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:25 PM ET
Size
20.0 KB